Nello Mainolfi sold $6M of KYMR stock

Nello Mainolfi, Chief Executive Officer of Kymera Therapeutics, Inc. (KYMR), sold 50,000 shares of KYMR stock worth $6M, per an SEC Form 4 filed Jul 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 7, 2026, 1 day before it was made public.

KYMR has moved +7.0% since the trade date, from $119.24 to $127.57 (Nov 13, 2026 close).